HIV Diagnostics Market Size By Test Type (Antibody Test, Viral Load Test, CD4 Test), By End-use (Diagnostic Laboratories, Hospitals & Clinics, Home Settings), Industry Analysis Report, Regional Outlook, Growth Potential, Covid-19 Impact Analysis, Price Tr

HIV Diagnostics Market Size By Test Type (Antibody Test, Viral Load Test, CD4 Test), By End-use (Diagnostic Laboratories, Hospitals & Clinics, Home Settings), Industry Analysis Report, Regional Outlook, Growth Potential, Covid-19 Impact Analysis, Price Trends, Competitive Market Share & Forecast, 2022 - 2028

The HIV diagnostics market is set to witness rapid growth through 2028 owing to rising HIV infections in under-developed and developed nations globally. In addition, rising adoption of home kits for diagnosis, along with increasing focus of government and private organizations on the development of effective diagnosis techniques, is anticipated to further drive the growth of the market over the forecast timeline.

According to the World Health Organization (WHO), in 2020, around 37.7 million people across the globe were living with HIV. Notably, nearly 40% of HIV infections are transmitted by people who are unaware that they have the virus. For people who have not been diagnosed, HIV testing is the first step towards maintaining a healthy life.

The Center for Disease Control and Prevention (CDC) suggests that everyone between the age of 13 and 64 should get tested for HIV at least once as part of their routine check-up. Moreover, people diagnosed with HIV should start treatment with antiretroviral therapy or ART. Not to mention, a large part of the fight against HIV globally has been raising awareness amongst people about the disease, including its diagnosis & testing and adoption of preventative drugs. To that effect, numerous non-governmental organizations are taking initiatives to spread awareness about HIV.

For instance, the Joint United Nations Programme on HIV/AIDS is a global unit that is leading the effort to wipe off the infection by 2030 internationally as part of its Sustainable Development Goals. For this purpose, the organization offers strategic direction, coordination, advocacy, and technical support to assist in connecting and catalyzing leadership from governments, communities, and private sector to provide life-saving HIV services. As a result, ongoing R&D activities in HIV diagnostics, like enhanced sensitivity for early or acute detection of the infection have created massive growth opportunities for the industry.

Overall, the HIV diagnostics market has been segregated in terms of test type, end-use and region. With reference to test type, the market has been classified into viral load test, antibody test, and CD4 tests. Among these, the antibody test segment held a market share of about 5% in 2021 and is poised to exhibit sturdy growth over 2022-2028. The growth of this segment is mainly due to the surging number of infections in underdeveloped and developing nations.

Based on end-use, the HIV diagnostics market has been segmented into hospitals & clinics, diagnostic laboratories, home settings, and others. The home settings segment is likely to depict a CAGR of more than 1.1% between 2022 and 2028 driven by the development of new in-home testing products.

From the regional point, the North America HIV diagnostics market exceeded a valuation of USD 60 million in 2021 and is set to observe moderate growth through the forecast period. Declining HIV cases are speculated to impede regional market growth.